TB-500 (Thymosin Beta-4) vs Wolverine Stack
TB-500 on its own versus the blend that pairs it with BPC-157.
How they actually differ
The Wolverine Stack contains the same 10 mg of TB-500 plus 10 mg of BPC-157, combining actin-driven cell migration with angiogenesis and growth-factor signalling. Handling is essentially TB-500's handling either way — its oxidation-prone methionine is the light-sensitive element that sets the rules for both the standalone vial and the blend. Choosing the blend is choosing to study two repair mechanisms together; choosing TB-500 alone isolates one.
TB-500 (Thymosin Beta-4) — origin
TB-500 corresponds to the active region of Thymosin Beta-4, a 43-residue actin-sequestering protein present in virtually every mammalian cell type and abundant in wound fluid and platelets. Research interest followed the observation that the protein's activity in tissue-organisation models is largely retained by a short fragment of it.
Wolverine Stack — origin
The Wolverine Stack combines the two most-studied tissue-repair peptides in a single 20 mg vial: BPC-157 (10 mg) and TB-500 (10 mg). It inherits the handling profile of both — the forgiving, gastric-derived BPC-157 and the oxidation-sensitive Thymosin-Beta-4 fragment TB-500 — so the blend is handled to the stricter of the two.
TB-500 (Thymosin Beta-4) research themes
The defining studied mechanism: binding G-actin and influencing the polymerisation equilibrium that governs cell motility.
Investigated in models where directed cell movement into a tissue defect is the measured endpoint.
Two of the better-populated preclinical literatures for the parent protein.
Studied for effects on inflammatory signalling in tissue-injury models.
Wolverine Stack research themes
BPC-157 is studied around angiogenesis and growth-factor signalling; TB-500 around actin-mediated cell migration — non-overlapping routes into tissue repair.
Studied together in connective-tissue and wound-healing research designs where both mechanisms are of interest.
Because their mechanisms do not overlap, the two are frequently examined in parallel rather than as substitutes for one another.
TB-500 (Thymosin Beta-4) handling
- Minimise headspace exposure — each opening introduces oxygen that drives methionine oxidation.
- Keep reconstituted vials out of direct light, including bench lighting over long sessions.
- Introduce diluent against the vial wall; the cake is light and can be dispersed by a direct stream before it dissolves.
Wolverine Stack handling
- Reach room temperature before opening; the cake is hygroscopic.
- Add diluent gently down the wall and swirl; do not shake or vortex.
- Keep out of light and portion early, since every opening exposes the oxidation-sensitive TB-500 component to fresh air.
Both third-party tested
Every Popular Peptides batch of TB-500 (Thymosin Beta-4) and Wolverine Stack is independently tested by HPLC and LC-MS with a published Certificate of Analysis. Enter a lot number to pull the COA for a specific vial.
TB-500 (Thymosin Beta-4) reference
Related comparisons
TB-500 (Thymosin Beta-4) and Wolverine Stack are supplied strictly as research chemicals for in-vitro laboratory and research use only. They are not intended for human or animal consumption, diagnostic, or therapeutic use. This comparison summarizes published preclinical literature and laboratory handling data; it is not medical advice, not a claim of efficacy, and not usage guidance.